BioCardia Reports Second Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 08/12/21
Will BioCardia, Inc. (BCDA) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/05/21
BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac TherapiesGlobeNewsWire • 07/15/21
BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021GlobeNewsWire • 06/02/21
BioCardia Reports First Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 05/13/21
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product CandidatesGlobeNewsWire • 04/26/21
BioCardia to Present at Maxim Group's Inaugural Emerging Growth Virtual ConferenceGlobeNewsWire • 03/15/21
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia's Board of DirectorsGlobeNewsWire • 01/11/21
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac TherapiesGlobeNewsWire • 12/30/20
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as DesignedGlobeNewsWire • 12/17/20
BioCardia's stock pulls back after taking advantage of recent doubling with another share saleMarket Watch • 12/16/20
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 12/16/20
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]GlobeNewsWire • 12/15/20
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 12/14/20